Antibiotice Ia

ATB · RO · Healthcare / Drug Manufacturers - Specialty & Generic

1.89RON+0.01 (+0.43%)

Price History

Full chart

Market Stats

Previous Close1.88

Open1.90

Day Range1.87 – 1.90

52-Week Range1.72 – 2.54

Volume16.02K

Market Cap1.28B

P/E (TTM)191.00

Forward P/E9.73

EPS0.01

Dividend Yield1.87%

Beta0.21

50-Day Avg1.97

200-Day Avg2.04

About

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for disinfecting surfaces and hands; and veterinary medicines. Its products are available in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, pessaries, and suppositories. It offers active pharmaceutical ingredients. The company exports its products to approximately 70 countries. Antibiotice S.A. was founded in 1955 and is headquartered in Iasi, Romania.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Ioan Nani
Employees1.35K
Headquarters1 Valea Lupului Street, Iasi, Romania, 707410, Romania
Websitehttps://www.antibiotice.ro

Leadership

Mr. Ioan NaniCEO & Director · b. 1959
Ms. Paula-Luminita ComanExecutive Director of Financial & CFO · b. 1968
Engineer Eugen Florin OsadetEngineering & Investment Director · b. 1957
Engineer Cornelia MoraruInvestors Relation Officer and Executive Director of Technical & Production · b. 1966
Ms. Liviu VatavuExecutive Director of Legal, Human Resources & Administration · b. 1971
Mr. Ovidiu BatagaExecutive Director of National Sales · b. 1978
Ms. Stefania AlexandruDeputy General Manager of Planning, Portfolio Management & Sales · b. 1984
Bogdan Mircea BabiciDeputy General Manager of Finance & Corporate Governance · b. 1977

Financials

Income Statement

Currency: RON	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	340.42M	366.21M	483.72M	600.78M	675.01M	645.28M
Growth (%)	-	+7.57%	+32.09%	+24.20%	+12.36%	-4.41%
Cost of Revenue	101.84M	136.42M	151.65M	191.38M	223.00M	222.41M
Gross Profit	238.59M	229.79M	332.08M	409.40M	452.01M	422.87M
Gross Margin	70.09%	62.75%	68.65%	68.15%	66.96%	65.53%
Operating Expense	195.96M	200.44M	261.21M	311.04M	348.05M	361.64M
Operating Income	42.63M	29.35M	70.87M	98.36M	103.96M	61.23M
Operating Margin	12.52%	8.01%	14.65%	16.37%	15.40%	9.49%
EBITDA	-	-	94.21M	123.60M	152.71M	117.61M
EBITDA Margin	-	-	19.48%	20.57%	22.62%	18.23%
Net Income	26.39M	29.94M	51.47M	81.09M	102.20M	51.77M
Net Income Margin	7.75%	8.18%	10.64%	13.50%	15.14%	8.02%
Interest Expense	4.93M	3.52M	3.59M	4.15M	4.54M	4.47M
Interest Expense % of Total Revenue	1.45%	0.96%	0.74%	0.69%	0.67%	0.69%

Balance Sheet

Currency: RON	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	-	863.00M	895.39M	856.47M	1.14B	1.28B	1.39B
Total Liabilities	-	285.73M	290.40M	215.04M	292.21M	384.95M	460.49M
Total Equity	-	577.27M	604.99M	641.43M	846.96M	894.31M	932.07M
Cash	-	6.33M	2.11M	1.73M	1.81M	2.68M	9.94M
Net Debt	-	154.68M	142.67M	79.25M	64.49M	138.03M	223.54M

Cash Flow

Currency: RON	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	-	-	-	-	-	-	115.66M	122.46M	95.15M	72.44M
Capital Expenditure	0	0	0	0	47.99M	29.05M	39.88M	98.04M	116.16M	142.61M
Free Cash Flow	-	-	-	-	46.06M	15.39M	65.68M	24.42M	-21.01M	-70.17M
Dividends Paid	-	-	-	-	18.17M	2.10M	2.00M	5.43M	48.17M	15.95M
FCF to OCF	-	-	-	-	-	-	56.79%	19.94%	-22.08%	-96.87%
Dividend Paid to FCF	-	-	-	-	39.44%	13.67%	3.05%	22.25%	-229.23%	-22.73%

Earnings

Report Date	May 13, 2014	Aug 14, 2014	Nov 14, 2014	Feb 13, 2015	May 15, 2015	May 15, 2017	Aug 16, 2017	Nov 15, 2017	Feb 14, 2018	May 14, 2018	Aug 14, 2018	Nov 14, 2018	Feb 28, 2019	May 15, 2019	Aug 16, 2019	Nov 15, 2019	Feb 26, 2020	May 12, 2020	Aug 14, 2020	Nov 13, 2020	Feb 17, 2021	May 17, 2021	Aug 13, 2021	Nov 12, 2021	Feb 23, 2022	May 10, 2022	Aug 12, 2022	Nov 18, 2022	Mar 1, 2023	May 9, 2023
EPS Estimate	0.03	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	0.02	0.00	0.00	0.02	0.00	0.01	0.03	0.00	0.02	0.00	0.03	0.00	0.05	0.00	0.03	0.00	0.05	0.01	0.02	0.00	0.04	0.01	0.02	0.00	0.04	0.01	0.02	0.01	0.06	0.00
Surprise	-33.33%	-	-100.00%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.28B

Enterprise Value1.63B

Trailing P/E191.00

Forward P/E9.73

PEG Ratio3.89

Price / Sales2.08

Price / Book1.38

EPS0.01

Book Value1.39

Revenue (TTM)616.58M

Gross Profit (TTM)353.67M

EBITDA83.34M

Profit Margin1.32%

Operating Margin10.35%

Return on Equity0.87%

Return on Assets1.11%

Shares Outstanding671.34M

Shares Float227.94M

Beta0.21

Dividend Yield1.87%

Dividend Rate0.04

Payout Ratio169.89%

Dividends

20261×

0.04Oct 15, 2026

20251×

0.02Sep 25, 2025

20241×

0.08Sep 23, 2024

20231×

0.01Sep 12, 2023

20221×

0.00Sep 12, 2022

20211×

0.00Sep 2, 2021

20201×

0.03Aug 28, 2020

20191×

0.01Sep 2, 2019

20181×

0.03Aug 30, 2018

20171×

0.04Aug 31, 2017

20161×

0.02Aug 31, 2016

20151×

0.02Sep 14, 2015

20141×

0.02May 13, 2014

20131×

0.02May 13, 2013

20121×

0.01May 11, 2012

Stock Splits

Jul 11, 20131.1819:1
May 12, 20111.1891:1
Nov 25, 20101.05:1